ASI Launches AMA PDRP Compliance Solutions and Services

    KING OF PRUSSIA, Pa.--Feb. 27, 2006--ASI officially announces the availability of its AMA PDRP Compliance solutions and services. With the AMA Prescribing Data Restriction Program (PDRP) taking effect on July 1, 2006, use of physician Rx data by pharmaceutical companies will never be the same again. ASI has extensively analyzed the AMA's program and mounting government legislation, and has developed a suite of compliance solutions and services.

    Strict adherence to the PDRP is mandatory and the AMA will directly and aggressively investigate all violations. The penalty for non-compliance is AMA license revocation and loss of access to all physician Rx data. Failure of this initiative will result in the enactment of pending government legislation. Without access to this information, existing sales and marketing business practices will be severely impacted and have potentially, devastating financial consequences.

    The PDRP prohibits access to physician level Rx data, which directly impacts First Line Managers, Sales Representatives, and anyone else that accesses or distributes physician Rx data. Prohibited/blocked data include Rx: counts, volume, projected volume, dollars, market share, percent, and any type of change indicators (color coding, up/down arrows, and directional indicators/alerts). Less specific, but more onerous are compliance with the stipulations of the program relative to the use of aggregated/segmented data and the reverse engineering rules.

    According to Jim Alonso, CEO, ASI Business Solutions, "An event of this proportion hasn't been felt by the pharmaceutical industry since the introduction of PDMA. The critical difference is that companies do not have 13 years to prepare. The complex HIPAA-style data privacy rules needed to comply with the program are very difficult to implement. If an organization believes that this can simply be addressed by dropping records, then they have not fully appreciated the magnitude of the program."

    PDRP will affect systems, procedures and policies associated with incentives, sales and adhoc reporting, physician targeting/pull through, SFA/CRM, customer segmentation, marketing messages, sales training, employee agreements, communications, compliance, reporting and information sharing policies.

    Since 1990, ASI Business Solutions has created cutting-edge, solutions for the Pharmaceutical Industry. For more information on a PDRP solution that will address compliance while maximizing the greatest amount of physician data permissible by the AMA, contact ASI--Your AMA PDRP Experts; email us at amapdrinfo@asi-solutions.com